-

Albert Invent, Whose Leading AI-Enabled End-to-End Platform Accelerates Innovation in Chemical and Materials R&D, Launches Subsidiary in Japan

Albert Invent Japan K.K. will be helmed by newly announced President, Dr. Larry Meixner

TOKYO--(BUSINESS WIRE)--Albert Invent, whose world-leading end-to-end artificial intelligence-driven platform is transforming R&D in the chemical and materials industries, today announced the launch of its Japanese subsidiary, Albert Invent Japan K.K., as part of the company’s continued global expansion. This investment reflects Albert’s deep commitment to supporting innovation in Japan’s world-class chemical and materials industry, which is the fourth largest in the world and has long been recognized for its technical excellence and scientific leadership.

"I have worked closely with Japanese researchers for many years, and their innovation is second to none. I have long believed that digital transformation is the key to accelerating the next era of Japanese chemical innovation,” said Dr. Meixner.

Share

Albert Invent Japan K.K. will be headquartered in Tokyo and staffed by a local team of Japanese experts in chemical and materials R&D, software, and customer engagement. Albert already serves a substantial number of researchers in Japan working at multi-national companies. The new subsidiary aims to provide Japanese corporations with full support across use case development, pilot implementation, platform onboarding, and technical services — all delivered locally. To lead this new entity, Albert Invent has appointed Dr. Larry Meixner as President.

“I am thrilled to be joining Albert Invent as President of Albert Invent Japan K.K. I have worked closely with Japanese researchers for many years, and their innovation is second to none. I have long believed that digital transformation is the key to accelerating the next era of Japanese chemical innovation,” said Dr. Meixner. “Digital transformation means more than just adding another AI tool. Albert offers a unique, integrated solution that I believe is unparalleled in the industry.”

Dr. Meixner’s career is deeply intertwined with Japan, including seven years as Managing Corporate Executive Officer, Chief Innovation Officer, and Chief Technology Officer of Mitsubishi Chemical Group. Prior to that, he was Deputy CTO of Sharp Corporation, while overseeing Sharp’s international R&D organization. Like the majority of Albert’s senior leadership, Dr. Meixner began his career at the bench, conducting hands-on R&D in chemistry and materials science at leading global corporations. He holds a B.S. in Chemical Engineering from the California Institute of Technology and a Ph.D. in Physical Chemistry from Stanford University.

“We built Albert Invent to deliver a modern system of record for the chemistry industry that enables the most sophisticated AI for material science, transforming laboratories and putting the tools to create the next generation of incredible products into chemists’ hands. We are thrilled to launch Albert Invent Japan K.K., and to welcome Dr. Larry Meixner to lead the organization,” said Nick Talken, cofounder and CEO, Albert Invent.

Albert Invent is expanding rapidly in the US and Europe, accelerating innovation for global companies including Henkel, Chemours, Nouryon, and more. Trained on over 15 million molecular structures, Albert’s Breakthrough platform enables chemists to develop safer and higher-performing products in a fraction of the time. Underpinning the platform is a powerful AI engine that centralizes data management, streamlines manufacturing, automates workflows, and enables real-time inventory management. Albert’s leading customers have seen a 50% increase in overall speed to market for products, as well as a 25% increase in chemist productivity, helping to optimize expertise and costs.

With the formation of Albert Invent Japan K.K., the company will bring this same capability to Japanese innovators — enabling domestic Japanese companies to compete at the highest levels of speed, precision, and innovation.

About Albert Invent

Albert Invent’s mission is to accelerate materials science innovation. Our cloud-based platform, designed specifically for chemistry and materials science, empowers thousands of scientists across 30+ countries to work faster and smarter in the lab. By providing intuitive digital workflows for entire organizations, Albert unifies experimental data, streamlines complex R&D and regulatory processes, and delivers AI-driven insights. This unique end-to-end solution dramatically speeds up innovation cycles and time-to-market for industry-leading companies worldwide. Founded by chemists and backed by top-tier investors including J.P. Morgan Private Capital Growth Equity Partners, Coatue, F-Prime, Homebrew, Index Ventures, and TCV, Albert Invent is based in Oakland, California. Discover how we're accelerating materials science at www.albertinvent.com.

Contacts

Jillian Harding
Command for Albert Invent
jill@heycommand.com

Albert Invent


Release Versions

Contacts

Jillian Harding
Command for Albert Invent
jill@heycommand.com

More News From Albert Invent

Albert Invent Deepens European Presence and Commitment to Scientific Innovation with Sponsorship of 2025 GDCh Annual Member Meeting

FRANKFURT AM MAIN, Germany--(BUSINESS WIRE)--Albert Invent, whose world-leading end-to-end AI-driven platform is transforming R&D in the chemical and materials industries, today announced its sponsorship of the Gesellschaft Deutscher Chemiker (GDCh) Annual Member Meeting, taking place November 13–14, 2025, in Frankfurt am Main. This year’s event is led by VCW, the division of GDCh focused on the economics and commercialization of chemical research, and how technological innovation impacts t...

Albert Invent Partners with Kenvue to Build the Future of Consumer Health Products With the Help of AI

SUMMIT, N.J. & OAKLAND, Calif.--(BUSINESS WIRE)--Frontier AI company Albert Invent today announced a strategic partnership with Kenvue Inc. (NYSE: KVUE), maker of consumer health products like Zyrtec®, Neutrogena®, and Listerine®, to accelerate end-to-end R&D efforts across the company’s global portfolio of brands. The partnership enables Kenvue to streamline, digitalize, and accelerate the end-to-end product lifecycle by leveraging Albert Invent's foundational AI models. The companies bega...

Chemistry AI Platform Albert Invent Announces Growth Investment Led by J.P. Morgan Private Capital

OAKLAND, Calif.--(BUSINESS WIRE)--Albert Invent, whose end-to-end R&D platform accelerates chemical innovation in materials science through the application of AI and machine learning, today announced a growth funding round led by J.P. Morgan Private Capital’s Growth Equity Partners, with participation from Coatue and TCV. This latest investment round brings Albert Invent’s total funding to more than $45M. The funds will be used to continue building the team globally, hiring in Germany, Japa...
Back to Newsroom